Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of cladribine treatment on microglial activation in the CNS
2024-519921-39-00Phase 4Authorised
- Sponsor
- Varsinais-Suomen hyvinvointialue
- Start
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of cladribine in multiple sclerosis (MS), sponsored by Varsinais-Suomen hyvinvointialue. Planned start Dec 2024; status: authorised.
02
Drugs
cladribine
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on 2024-519921-39-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-519921-39-00.